5 Best Nano-Cap Stocks To Buy For 2022

2. Lipocine Inc. (NASDAQ:LPCN)

Market Cap as of October 14: $39.8 Million

Number of Hedge Fund Holders: 5

Lipocine Inc. (NASDAQ:LPCN) is a clinical-stage biopharmaceutical company that is involved in the research and development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company’s flagship product is TLANDO, an oral testosterone replacement therapy. On September 15, Lipocine Inc. (NASDAQ:LPCN) announced that it has received FDA approval for establishing the efficacy of LPCN 1154, an oral neuroactive steroid for the treatment of postpartum depression. The company is profitable and undervalued and is one of the best micro-cap stocks to invest in for 2022. As of October 14, the stock is trading at a PE multiple of 11x and has a trailing twelve-month operating margin of 15.57%.

At the close of the second quarter of 2022, 4 hedge funds held stakes in Lipocine Inc. (NASDAQ:LPCN). The total value of these stakes amounted to $886,000. As of June 30, Marshall Wace LLP is the top shareholder in Lipocine Inc. (NASDAQ:LPCN) and has stakes worth $353,000 in the company.